- Home
- LAUR vs PRCT Comparison
LAUR vs PRCT Comparison
Compare LAUR & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAUR
- PRCT
- Stock Information
- Founded
- LAUR 1989
- PRCT 2009
- Country
- LAUR United States
- PRCT United States
- Employees
- LAUR N/A
- PRCT N/A
- Industry
- LAUR Other Consumer Services
- PRCT Medical Specialities
- Sector
- LAUR Real Estate
- PRCT Health Care
- Exchange
- LAUR Nasdaq
- PRCT Nasdaq
- Market Cap
- LAUR 3.4B
- PRCT 3.2B
- IPO Year
- LAUR 2017
- PRCT 2021
- Fundamental
- Price
- LAUR $23.18
- PRCT $56.89
- Analyst Decision
- LAUR Buy
- PRCT Strong Buy
- Analyst Count
- LAUR 2
- PRCT 7
- Target Price
- LAUR $20.50
- PRCT $90.00
- AVG Volume (30 Days)
- LAUR 808.2K
- PRCT 780.1K
- Earning Date
- LAUR 07-31-2025
- PRCT 07-31-2025
- Dividend Yield
- LAUR N/A
- PRCT N/A
- EPS Growth
- LAUR 143.51
- PRCT N/A
- EPS
- LAUR 1.90
- PRCT N/A
- Revenue
- LAUR $1,527,432,000.00
- PRCT $249,121,000.00
- Revenue This Year
- LAUR $2.45
- PRCT $47.40
- Revenue Next Year
- LAUR $6.85
- PRCT $31.55
- P/E Ratio
- LAUR $12.28
- PRCT N/A
- Revenue Growth
- LAUR 1.26
- PRCT 59.36
- 52 Week Low
- LAUR $13.60
- PRCT $47.04
- 52 Week High
- LAUR $23.61
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- LAUR 61.86
- PRCT 43.53
- Support Level
- LAUR $22.47
- PRCT $56.27
- Resistance Level
- LAUR $23.55
- PRCT $58.62
- Average True Range (ATR)
- LAUR 0.52
- PRCT 1.87
- MACD
- LAUR 0.05
- PRCT -0.59
- Stochastic Oscillator
- LAUR 80.79
- PRCT 12.93
About LAUR Laureate Education Inc.
Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.